3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
9
Prostatic Neoplasms
8
Pancreatic Neoplasms
6
Uterine Cervical Neoplasms
4
Neoplasms
4
Brain Neoplasms
4
Triple Negative Breast Neoplasms
3
Rectal Neoplasms
3
Lymphoma, Non-Hodgkin
3
Lymphoma
3
Lung Neoplasms
3
Liver Neoplasms
3
Urinary Bladder Neoplasms
2
Stomach Neoplasms
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Leukemia
2
Hodgkin Disease
2
Glioma
2
Esophageal Neoplasms
2
Disease
2
Colonic Neoplasms
2
Carcinoma, Neuroendocrine
2
Carcinoma, Hepatocellular
2
Carcinoma in Situ
2
Vulvar Neoplasms
1
Vulvar Diseases
1
Uterine Cervical Dysplasia
1
Thoracic Neoplasms
1
Thoracic Diseases
1
Spinal Diseases
1
Interventions
pembrolizumab
4
Proton Therapy
3
toripalimab
1
spartalizumab
1
patritumab deruxtecan
1
osimertinib
1
mirdametinib
1
leronlimab
1
amivantamab
1
Valganciclovir
1
Radiotherapy
1
Paclitaxel
1
Lacteol
1
Interleukin-2
1
Docetaxel
1
Carboplatin
1
Blood Specimen Collection
1
Bevacizumab
1
BGB-283
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Solid Tumor, Adult
×
Magnetic Resonance Imaging
×
1 year
×
Clear all
No trials found.